Transplant-Associated and Blood Transfusion-Associated Tropical and Parasitic Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 2, 2012, Pages 225-241

  Machado, Clarisse Martins ^a,b   Levi, José Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Amaral Carvalho Foundation   (Brazil)

Author keywords

Blood transfusion; Donors; Parasites; Transmission; Transplantation; Tropical diseases

Indexed keywords

BACTERIAL TRANSMISSION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; BRUCELLOSIS; CHAGAS DISEASE; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LEISHMANIASIS; MALARIA; ORGAN TRANSPLANTATION; PARASITE TRANSMISSION; PARASITOSIS; RABIES; REVIEW; SCREENING TEST; TROPICAL DISEASE; TUBERCULIN TEST; TUBERCULOSIS; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; MASS SCREENING; ORGAN TRANSPLANTATION; PARASITIC DISEASES; TROPICAL CLIMATE;

EID: 84861474222     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.02.008     Document Type: Review

References (68)

1. Machado C.M. Transplant infections in developing countries. Transplant infections 2010, 90-103. Lippincott Williams and Wilkins, Philadelphia. 3rd edition. R.A. Bowden, P. Ljungman, D.R. Snydman (Eds.).
2. Zou S., Dodd R.Y., Stramer S.L., et al. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004, 351(8):751-759.
3. Morris M.I., Fischer S.A., Ison M.G. Infections transmitted by transplantation. Infect Dis Clin North Am 2010, 24(2):497-514.
4. World Health Organization Global tuberculosis control 2011, World Health Organization, Geneva, Available at:, Accessed February 29, 2012. http://www.who.int/tb/publications/global_report/en/index.html.
5. Rose D.N. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 2000, 160(10):1513-1521.
6. Aguado J.M., Herrero J.A., Gavalda J., et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997, 63(9):1278-1286.
7. Munoz P., Rodriguez C., Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005, 40(4):581-587.
8. Singh N., Paterson D.L. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998, 27(5):1266-1277.
9. Koseoglu F., Emiroglu R., Karakayali H., et al. Prevalence of mycobacterial infection in solid organ transplant recipients. Transplant Proc 2001, 33(1-2):1782-1784.
10. Batista M.V., Pierrotti L.C., Abdala E., et al. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 2011, 16(9):1134-1142.
11. Machado C.M., Martins T.C., Colturato I., et al. Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center. Rev Inst Med Trop Sao Paulo 2009, 51(6):309-324.
12. Centers for Disease Control and Prevention (CDC) Transplantation-transmitted tuberculosis-Oklahoma and Texas, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(13):333-336.
13. Targeted tuberculin testing and treatment of latent tuberculosis infection: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this statement as it relates to infants and children were endorsed by the American Academy of Pediatrics (AAP), August 1999. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-S247.
14. Subramanian A., Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S57-S62.
15. Kotton C.N. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007, 44(6):857-866.
16. Al-Anazi K.A., Jafar S.A., Al-Jasser A.M., et al. Brucella bacteremia in a recipient of an allogeneic hematopoietic stem cell transplant: a case report. Cases J 2009, 2(1):91.
17. Aregawi M, Cibulskis R, Lynch M, et al. World Malaria Report 2011. Available at: Accessed April 3, 2012. http://www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf.
18. Martin-Davila P., Fortun J., Lopez-Velez R., et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 2008, 21(1):60-96.
19. Reesink H.W., Panzer S., Wendel S., et al. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010, 98(3 Pt 2):468-478.
20. Owusu-Ofori A.K., Parry C., Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010, 51(10):1192-1198.
21. Chiche L., Lesage A., Duhamel C., et al. Posttransplant malaria: first case of transmission of Plasmodium falciparum from a white multiorgan donor to four recipients. Transplantation 2003, 75(1):166-168.
22. Fischer L., Sterneck M., Claus M., et al. Transmission of malaria tertiana by multi-organ donation. Clin Transplant 1999, 13(6):491-495.
23. Menichetti F., Bindi M.L., Tascini C., et al. Fever, mental impairment, acute anemia, and renal failure in patient undergoing orthotopic liver transplantation: posttransplantation malaria. Liver Transpl 2006, 12(4):674-676.
24. Tomblyn M., Chiller T., Einsele H., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15(10):1143-1238.
25. Schofield C.J., Jannin J., Salvatella R. The future of Chagas disease control. Trends Parasitol 2006, 22(12):583-588.
26. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007, 298(18):2171-2181.
27. Centers for Disease Control and Prevention (CDC) Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 2006, 55(29):798-800.
28. Centers for Disease Control and Prevention (CDC) Blood donor screening for chagas disease-United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2007, 56(7):141-143.
29. Dias J.P., Bastos C., Araujo E., et al. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 2008, 41(3):296-300.
30. Freitas J.L.P., Amato V., Sonntag R., et al. Primeiras verificacoes de transmissao acidental da molestia de Chagas ao homem por transfusao de sangue. Rev Paul Med 1952, 40:36-40. [in Portuguese].
31. Wendel S. Transfusion transmitted Chagas disease: is it really under control?. Acta Trop 2010, 115(1-2):28-34.
32. Schmunis G.A., Cruz J.R. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005, 18(1):12-29.
33. Pinazo M.J., Miranda B., Rodriguez-Villar C., et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando) 2011, 25(3):91-101.
34. Chocair P.R., Sabbaga E., Amato Neto V., et al. Rev Inst Med Trop Sao Paulo 1981, 23(6):280-282. [in Portuguese].
35. Bacal F., Silva C.P., Pires P.V., et al. Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant 2010, 24(2):E29-E34.
36. D'Albuquerque L.A., Gonzalez A.M., Filho H.L., et al. Liver transplantation from deceased donors serologically positive for Chagas disease. Am J Transplant 2007, 7(3):680-684.
37. From the Centers for Disease Control and Prevention. Chagas disease after organ transplantation-United States, 2001. JAMA 2002, 287(14):1795-1796.
38. Chin-Hong P.V., Schwartz B.S., Bern C., et al. Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group. Am J Transplant 2011, 11(4):672-680.
39. Bocchi E.A., Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001, 71(6):1833-1838.
40. Cruz I., Morales M.A., Noguer I., et al. Leishmania in discarded syringes from intravenous drug users. Lancet 2002, 359(9312):1124-1125.
41. WHO Expert Committee on the Control of Leishmaniases. Control of the Leishmaniases - WHO Technical Series (949) 2010, World Health Organization, Geneva, Available at:, Accessed February 29, 2012. http://new.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=16971&Itemid=.
42. Dey A., Singh S. Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol 2006, 24(3):165-170.
43. Scarlata F., Vitale F., Saporito L., et al. Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 2008, 102(4):394-396.
44. Antinori S., Cascio A., Parravicini C., et al. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 2008, 8(3):191-199.
45. Basset D., Faraut F., Marty P., et al. Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 2005, 7(13):1370-1375.
46. Zou S., Stramer S.L., Dodd R.Y. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2011, 26(2):119-128.
47. Quarto M., Germinario C., Fontana A., et al. HIV transmission through kidney transplantation from a living related donor. N Engl J Med 1989, 320(26):1754.
48. Stramer S.L., Wend U., Candotti D., et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011, 364(3):236-247.
49. Vermeulen M., Lelie N., Sykes W., et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009, 49(6):1115-1125.
50. Ison M.G., Llata E., Conover C.S., et al. Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant 2011, 11(6):1218-1225.
51. Humar A., Morris M., Blumberg E., et al. Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant 2010, 10(4):889-899.
52. Candotti D., Allain J.P. Transfusion-transmitted hepatitis B virus infection. J Hepatol 2009, 51(4):798-809.
53. Gerlich W.H., Wagner F.F., Chudy M., et al. HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2011, 79:S32-S36.
54. Pruss A., Caspari G., Kruger D.H., et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis 2010, 12(5):375-386.
55. Choo Q.L., Kuo G., Weiner A.J., et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
56. Negro F., Alberti A. The global health burden of hepatitis C virus infection. Liver Int 2011, 31(Suppl 2):1-3.
57. Frank C., Mohamed M.K., Strickland G.T., et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355(9207):887-891.
58. Alter H.J., Klein H.G. The hazards of blood transfusion in historical perspective. Blood 2008, 112(7):2617-2626.
59. Roth W.K., Busch M.P., Schuller A., et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012, 102(1):82-90.
60. Levi J.E. Arboviruses and transfusion transmitted infectious diseases. ISBT Sci Ser 2011, 6(1):116-118.
61. Linnen J.M., Vinelli E., Sabino E.C., et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008, 48(7):1355-1362.
62. Rigau-Perez J.G., Vorndam A.V., Clark G.G. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg 2001, 64(1-2):67-74.
63. Tan F.L., Loh D.L., Prabhakaran K., et al. Dengue haemorrhagic fever after living donor renal transplantation. Nephrol Dial Transplant 2005, 20(2):447-448.
64. Wiwanitkit V. Unusual mode of transmission of dengue. J Infect Dev Ctries 2010, 4(1):51-54.
65. De S.G., Dallaire F., Cote M., et al. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 2008, 46(9):1329-1337.
66. Rupprecht C.E., Hanlon C.A., Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002, 2(6):327-343.
67. Bronnert J., Wilde H., Tepsumethanon V., et al. Organ transplantations and rabies transmission. J Travel Med 2007, 14(3):177-180.
68. Manning S.E., Rupprecht C.E., Fishbein D., et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008, 57(RR-3):1-28.